Genia Technologies
Advancing genomic sequencing to the $100 genome, bringing high-speed, accurate, and sensitive DNA sequencing into everyday life.
Advancing genomic sequencing to the $100 genome, bringing high-speed, accurate, and sensitive DNA sequencing into everyday life.
Genia Technologies is a biotechnology startup focused on advancing genomic sequencing to the $100 genome, making DNA sequencing more accessible for everyday use. The company, founded in 2009 and based in Mountain View, CA, aims to lower sequencing costs while enhancing speed, accuracy, and sensitivity. Genia's technology utilizes Biological Nanopores for the Structure-Based Sequencing of Single DNA Molecules, moving away from amplification, complex fluidics, and optical detection. Recently, the company completed its Series A funding round with a $10.44M Debt Financing investment from a publicly traded global biotech firm on 29 May 2013. This positions Genia Technologies to potentially disrupt the genomics industry and drive innovation in healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $10.44M | - | 29 May 2013 |
No recent news or press coverage available for Genia Technologies.
We care about your data, and we'd love to use cookies make your experience better.